AI assistant
Sending…
AbbVie Inc. — Director's Dealing 2023
Mar 2, 2023
29755_dirs_2023-03-02_af59b467-03f2-401b-b52e-36427307c4dc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2023-02-28
Reporting Person: Strom Carrie C (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-02-28 | Common Stock, $0.01 par value | F | 5762 | $154.28 | Disposed | 32159 | Direct |
| 2023-03-02 | Common Stock, $0.01 par value | F | 810 | $155.27 | Disposed | 31349 | Direct |
More from AbbVie Inc.
Regulatory Filings
2026
May 12
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 29
Regulatory Filings
2026
Apr 3
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 23
Proxy Solicitation & Information Statement
2026
Mar 23
Regulatory Filings
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4